Cafepharma Today

May 13 2025 - GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs
Elizabeth Holmes’s partner reportedly raises millions for blood-testing startup
Bluebird bio warns of potential bankruptcy after another buyout delay
HIV market expected to reach $32.1bn by 2033 in 7MM
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This Week in Biotech
Motley Fool
Sunday, August 25, 2013 - 11:27am
tags:
Supernus Pharmaceuticals, Novartis, Pain Therapeutics, GTx
Teva Shares Are Too Cheap
Barron's
Saturday, August 24, 2013 - 12:05pm
tags:
Teva Pharmaceuticals
Horizon Pharma Announces Settlement of Duexis Patent Litigation With Par Pharmaceutical
Healthcare Global
Saturday, August 24, 2013 - 12:04pm
tags:
Horizon, Par, Duexis, generics
Johnson & Johnson's 3 Most Promising Drugs (video)
Motley Fool
Saturday, August 24, 2013 - 12:00pm
tags:
Zytiga, Pharmacyclics, JNJ, Invokana, ibrutinib
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, August 24, 2013 - 11:48am
tags:
ChemoCentryx, Aglos Pharmaceuticals, Prosensa
What's the Big Deal About Onyx Anyway?
Motley Fool
Saturday, August 24, 2013 - 11:47am
tags:
ONYX Pharmaceuticals, Amgen, M&A
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, August 24, 2013 - 11:46am
tags:
Incyte, Novartis, Astex, Pacific Biosciences
Affymax: Putting The Pieces Together
Seeking Alpha
Saturday, August 24, 2013 - 11:45am
tags:
Affymax
Don't Miss These 3 Healthcare Sweet Spots
Seeking Alpha
Saturday, August 24, 2013 - 11:44am
tags:
Celldex, Keryx, Sarepta Therapeutics
Pop-Worthy Data, Incyte, but Let's See More
Motley Fool
Saturday, August 24, 2013 - 11:42am
tags:
Incyte, Jakafi, pancreatic cancer
Onyx Takeover Brewing In Hot Biotech Industry
Yahoo/Investor's Business Daily
Saturday, August 24, 2013 - 11:40am
tags:
ONYX Pharmaceuticals, Amgen, M&A
Cytokinetics' Tirasemtiv Data Published
Yahoo/Zacks
Saturday, August 24, 2013 - 11:39am
tags:
Cytokinetics, Tirasemtiv, amyotrophic lateral sclerosis, Lou Gehrig's disease
Biogen Multiple Sclerosis Drug May Become Blockbuster
investors.com
Saturday, August 24, 2013 - 11:38am
tags:
Biogen Idec, MS, multiple sclerosis, Tecfidera
Merrimack Study Data Published
Yahoo/Zacks
Saturday, August 24, 2013 - 11:36am
tags:
Merrimack Pharmaceuticals, MM-398, pancreatic cancer
New entrant in obesity drug race targets body, not the mind
Reuters
Saturday, August 24, 2013 - 11:35am
tags:
Zafgen, obesity, weight loss. Beloranib
3 Positives From J&J's Latest Acquisition
Motley Fool
Saturday, August 24, 2013 - 11:33am
tags:
M&A, JNJ, Aragon
Arena's Belviq Sales Results, 10 Weeks In
Seeking Alpha
Friday, August 23, 2013 - 12:01pm
tags:
Belviq, Eisai, obesity, Arena Pharmaceuticals
A Pfizer Whistleblower, Lipitor Marketing And Free Speech Rights
Pharmalot
Friday, August 23, 2013 - 11:55am
tags:
Lipitor, Pfizer, whistleblower lawsuits, free speech
Storm clouds getting darker for troubled Seattle biotech Dendreon
Marketwatch
Friday, August 23, 2013 - 11:52am
tags:
Dendreon
Good News for Mylan's Generic Unit
Yahoo/Zacks
Friday, August 23, 2013 - 11:13am
tags:
generics, Mylan, Wellbutrin XL, GSK

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline
Treating Orthopox Viruses - With What?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.